Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.
Saved in:
| Title: | Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial. |
|---|---|
| Authors: | Weintraub MJ; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America. Electronic address: mjweintraub@mednet.ucla.edu., Jeffrey JK; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Ichinose MC; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Bergman RL; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Shapiro B; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Barnett G; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Artin H; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Lynn M; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Salimian A; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Grody S; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Ramesh R; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Eales L; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America., Grob CS; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America; The Lunquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center, United States of America., Miklowitz DJ; UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, United States of America. |
| Source: | Journal of affective disorders [J Affect Disord] 2026 Jun 15; Vol. 403, pp. 121423. Date of Electronic Publication: 2026 Feb 16. |
| Publication Type: | Journal Article; Clinical Trial |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
